Ovid Therapeutics Inc.
OVID
$1.55
-$0.01-0.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -159.56% | 54.24% | -10.61% | 33.94% | -264.39% |
| Total Depreciation and Amortization | -83.84% | -29.79% | -11.88% | -5.33% | 14.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.91% | -5.55% | 1,901.61% | -110.78% | 102.12% |
| Change in Net Operating Assets | -35.93% | 4.53% | -52.75% | 51.12% | -141.67% |
| Cash from Operations | -169.63% | 53.56% | -2.72% | 33.31% | -5.28% |
| Capital Expenditure | -- | -- | -- | -650.00% | 111.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.08% | 136.24% | -76.06% | 7,300.69% | -97.76% |
| Cash from Investing | -58.08% | 136.24% | -76.04% | 7,191.78% | -97.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -89.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -100.00% | -89.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.21% | 240.93% | -145.77% | 176.88% | -1,261.50% |